Addus HomeCare (NASDAQ:ADUS) Rating Increased to Buy at StockNews.com

Addus HomeCare (NASDAQ:ADUS) was upgraded by investment analysts at StockNews.com from a “hold” rating to a “buy” rating in a research note issued to investors on Wednesday.

A number of other equities analysts also recently weighed in on ADUS. Macquarie reaffirmed an “outperform” rating and set a $139.00 price target on shares of Addus HomeCare in a research report on Monday, November 4th. Oppenheimer lifted their price target on Addus HomeCare from $140.00 to $145.00 and gave the stock an “outperform” rating in a report on Monday, September 23rd. KeyCorp began coverage on shares of Addus HomeCare in a research report on Friday, October 11th. They issued an “overweight” rating and a $150.00 price objective on the stock. Royal Bank of Canada reissued an “outperform” rating and set a $136.00 price target on shares of Addus HomeCare in a report on Thursday, November 14th. Finally, Stephens lifted their price objective on shares of Addus HomeCare from $143.00 to $145.00 and gave the stock an “overweight” rating in a research note on Wednesday, November 6th. One equities research analyst has rated the stock with a sell rating, eight have issued a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, Addus HomeCare presently has an average rating of “Moderate Buy” and an average price target of $131.63.

Addus HomeCare Trading Up 1.9 %

Addus HomeCare stock opened at $122.96 on Wednesday. The firm has a market capitalization of $2.23 billion, a P/E ratio of 28.14, a PEG ratio of 2.11 and a beta of 1.02. The business has a 50-day moving average of $125.90 and a 200-day moving average of $124.32. Addus HomeCare has a 1 year low of $85.94 and a 1 year high of $136.12.

Addus HomeCare (NASDAQ:ADUS) last released its quarterly earnings data on Monday, November 4th. The company reported $1.30 earnings per share for the quarter, beating the consensus estimate of $1.28 by $0.02. The business had revenue of $289.80 million for the quarter, compared to analysts’ expectations of $289.42 million. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. Addus HomeCare’s revenue for the quarter was up 7.1% on a year-over-year basis. During the same quarter in the previous year, the business posted $1.03 EPS. Research analysts anticipate that Addus HomeCare will post 4.59 EPS for the current fiscal year.

Insider Activity at Addus HomeCare

In other Addus HomeCare news, CEO R Dirk Allison sold 12,500 shares of the stock in a transaction dated Monday, November 25th. The stock was sold at an average price of $123.16, for a total value of $1,539,500.00. Following the completion of the transaction, the chief executive officer now directly owns 141,897 shares in the company, valued at approximately $17,476,034.52. This trade represents a 8.10 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Roberton James Stevenson sold 2,250 shares of Addus HomeCare stock in a transaction that occurred on Monday, December 9th. The stock was sold at an average price of $121.00, for a total transaction of $272,250.00. Following the sale, the executive vice president now owns 10,217 shares in the company, valued at approximately $1,236,257. This represents a 18.05 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 4.60% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently modified their holdings of the company. UMB Bank n.a. increased its position in Addus HomeCare by 64.2% in the 2nd quarter. UMB Bank n.a. now owns 225 shares of the company’s stock valued at $26,000 after buying an additional 88 shares in the last quarter. Quarry LP bought a new stake in shares of Addus HomeCare in the 3rd quarter worth approximately $28,000. Quest Partners LLC bought a new stake in shares of Addus HomeCare in the second quarter valued at $31,000. Innealta Capital LLC bought a new stake in Addus HomeCare in the 2nd quarter valued at about $44,000. Finally, Farther Finance Advisors LLC lifted its stake in shares of Addus HomeCare by 9,150.0% during the 3rd quarter. Farther Finance Advisors LLC now owns 370 shares of the company’s stock valued at $49,000 after buying an additional 366 shares in the last quarter. Institutional investors and hedge funds own 95.35% of the company’s stock.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.